Novartis exec makes Ipsen switch

Harout Semerjian has been named Ipsen’s (Euronext: IPN) new head of specialty care, international region and global franchises.

He joins the French drugmaker from Swiss pharma giant Novartis (NOVN: VX), becoming a member of Ipsen’s executive leadership team.

Mr Semerjian has spent more than 23 years working in pharma, including the last 17 with Novartis, focused on oncology and specialty care. He took on leadership roles with increasing responsibility across the USA, Canada, Europe, Middle East and North Africa in addition to headquarter-based roles.